p53、Ki-67、PCNA的表达与食管鳞癌放疗近期疗效及预后的关系-东南大学学报医学版

p53、Ki-67、PCNA的表达与食管鳞癌放疗近期疗效及预后的关系

单位：1. 蚌埠医学院, 安徽蚌埠 233000;
2. 蚌埠医学院附属解放军82医院肿瘤中心, 江苏淮安 223001

分类号：R735.1;R815

出版年·卷·期（页码）：2017·36·第二期（155-161）

摘要：

目的：探讨食管鳞癌组织中p53、Ki-67及增殖细胞核抗原（PCNA）的表达与食管癌患者放疗近期疗效及预后的关系。方法：收集接受放疗的食管癌患者83例，采用免疫组化方法检测活检癌组织中p53、Ki-67及PCNA的表达，并分析其与临床病理特征、放疗疗效和预后的关系。结果：p53、Ki-67及PCNA在食管鳞癌中高表达率分别为57.8%、72.3%、67.5%。p53、Ki-67及PCNA表达与性别、年龄、侵犯部位、肿瘤长度等各临床病理因素无关（P>0.05），p53与肿瘤分化程度、临床分期、淋巴结转移、放疗近期疗效明显相关（P<0.05），Ki-67与肿瘤分化程度、淋巴结转移、放疗近期疗效明显相关（P<0.05），PCNA与临床分期、淋巴结转移、放疗近期疗效明显相关（P<0.05）。p53低、高表达组食管癌患者3年总生存率分别为57.14%、27.08%。结论：p53、Ki-67及PCNA可作为评价食管癌恶性程度、放射敏感性的生物学指标，p53可作为评价食管癌预后的有效指标。

Objective: To explore the expression of p53, Ki-67 and proliferating cell nuclear antigen(PCNA) in esophageal squamous cell carcinoma and its relation with radiotherapy effect and prognosis. Methods: Eighty-three esophageal carcinoma patients who underwent esophageal radiotherapy in our hosiptal were analyzed. Expressions of p53,Ki-67and PCNA were detected by immunohistochemistry, and its relation with clinicopathologic features, radiotherapy effect and survival rate of esophageal carcinoma patients was analyzed. Results: The positive expression rates of p53,Ki-67and PCNA were 57.8%,72.3%and 67.5%, respectively. The expressions of p53,Ki-67and PCNA in different gender,age,tumor position and size had no statistical differences(P>0.05).p53 was related to the tumor differentiation degree, clinical stage,lymph node metastasis and radiotherapy effect(P<0.05).Ki-67 was related to the tumor differentiation degree,lymph node metastasis and radiotherapy effect (P<0.05). PCNA was related to the clinical stage,lymph node metastasis and radiotherapy effect (P<0.05).Three years overall survival rates of patients in low and high p53 expression groups were 57.14% and 27.08%,respectively. Conclusion: p53, Ki-67 and PCNA can be used as the predictive markers for judguing malignant degree and radiosensitivity of esophageal carcinoma.p53 will be a useful marker for evaluating the prognosis of esophageal carcinoma.

参考文献：

[1] LÜ Y J,ZHANG J D,QIAO L L.Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy[J].Mol Clin Oncol,2014,2(5):870-874.
[2] 中国非手术治疗食管癌临床分期专家小组.非手术治疗食管癌的临床分期标准(草案)[J].中华放射肿瘤学杂志,2010,19(3):179-180.
[3] 陈建洲,陈创珍,李德锐,等.非手术治疗食管癌临床分期的验证[J].中国肿瘤,2011,21(5):374-378.
[4] 韩春,任雪姣,王澜,等.钡餐造影结合CT评价食管癌放疗近期疗效的研究[J].中华放射肿瘤学杂志,2013,22(1):26-29.
[5] 余辉,吴一龙,戎铁华,等.p53、C-erb-2、VEGF蛋白表达对非小细胞肺癌辅助放疗的临床预测[J].中华肿瘤杂志,2004,26(1):44.
[6] 雷蕾,叶斌,王西川.p53和Ki-67在食管癌中的表达及其临床意义[J].中国医药指南,2014,12(9):10-11.
[7] 马怀幸,刘伟巍,李世伟,等.p53状态与食管鳞癌预后及临床病理特征关系的系统评价[J].世界华人消化杂志,2015,23(36):5829-5842.
[8] WANG L H,YU X D,LI J,et al.Prognostic significance of p53 expression in patients with esophageal cancer:a meta-analysis[J].BMC Cancer,2016,16:373.
[9] ZOLOTA V,BATISTATOU A,TSAMANDAS A C,et al.Immunohistochemiocal expression of TGF-betal,p21 WAF1,p53,Ki-67,and angiogenesis in gastric carcinomas:a clinicopathologic study[J].Int J Gastrointest Cancer,2002,32(2-3):83-89.
[10] 任金山,吴红芳.Ki-67与食管鳞癌放疗敏感性的相关研究[J].中国现代药物应用,2011,5(8):37-38.
[11] OKUNO Y,NISHMURA Y,KASHU I,et al.Prognosticvalues of prolifera ting cell nuclear antigen PCNA and Ki-67 for radiotherapy of esophageal squamous cell carcinomas[J].Br J Cancer,1999,80(3-4):387-395.
[12] HICKEY K,GREHAN D,REID I M,et al.Expression of epidermal growth factor recepter and prolifer ating cell nuclear antigenepredicts response of esophageal sqamous cell carcinoma to chemoradiotherapy[J].Cancer,1994,74(6):1693-1698.
[13] 张丽珍,程炳权,杨伟志.PCNA及nm23的表达与食管鳞癌放射敏感性及预后的相关性研究[J].中华放射肿瘤学杂志,2001,10(4):239-242.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录